Results 221 to 230 of about 217,168 (254)
Some of the next articles are maybe not open access.
Journal of Clinical Oncology, 1996
PURPOSE Circulating melanoma cells can be detected in peripheral blood by means of tyrosinase mRNA amplification by reverse-transcriptase polymerase chain reaction (RT-PCR). We conducted a prospective study to evaluate the clinical significance of the presence of circulating neoplastic cells in the blood of patients with malignant melanoma (MM ...
B, Mellado +9 more
openaire +2 more sources
PURPOSE Circulating melanoma cells can be detected in peripheral blood by means of tyrosinase mRNA amplification by reverse-transcriptase polymerase chain reaction (RT-PCR). We conducted a prospective study to evaluate the clinical significance of the presence of circulating neoplastic cells in the blood of patients with malignant melanoma (MM ...
B, Mellado +9 more
openaire +2 more sources
Annales de dermatologie et de venereologie, 1998
Circulating melanocytes can be detected in peripheral blood of patients with malignant melanoma by means of tyrosinase messenger RNA amplification. In this study we especially examined peripheral blood from patients with stage II melanoma before and after lymph node dissection for the detection of these circulating melanoma cells.
M H, Tessier +3 more
openaire +1 more source
Circulating melanocytes can be detected in peripheral blood of patients with malignant melanoma by means of tyrosinase messenger RNA amplification. In this study we especially examined peripheral blood from patients with stage II melanoma before and after lymph node dissection for the detection of these circulating melanoma cells.
M H, Tessier +3 more
openaire +1 more source
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Heather A Parsons +2 more
exaly
Clinical cancer research : an official journal of the American Association for Cancer Research, 2001
Despite the large number of studies performed in solid tumors, few attempts at molecular detection of urothelial cells in blood have been made. Specifically, only uroplakin II (UP-II) and cytokeratin 20 (CK-20) have been suggested as tumor markers in the blood of bladder cancer patients. Epidermal growth factor receptor (EGFR) mRNA expression was found
GAZZANIGA, PAOLA +9 more
openaire +2 more sources
Despite the large number of studies performed in solid tumors, few attempts at molecular detection of urothelial cells in blood have been made. Specifically, only uroplakin II (UP-II) and cytokeratin 20 (CK-20) have been suggested as tumor markers in the blood of bladder cancer patients. Epidermal growth factor receptor (EGFR) mRNA expression was found
GAZZANIGA, PAOLA +9 more
openaire +2 more sources
S-Domain Modeling of Neoplastic Cells Circulation in Mice
2020Andrzej Świerniak +2 more
openaire +1 more source
[Invasion of neoplastic cells into the circulation].
Revista brasileira de cirurgia, 1998E T, TORRES, F, PAULINO
openaire +1 more source
695 ROLE OF CIRCULATING NEOPLASTIC PROGENITOR CELLS IN DETECTION AND STAGING OF PROSTATE CANCER
Journal of Urology, 2010Armine Smith +4 more
openaire +1 more source
Diagnosis and Treatment of Neoplastic Effusions
Ca-A Cancer Journal for Clinicians, 1962J E Ultmann
exaly
Nutritional and Dietary Factors in Neoplastic Development
Ca-A Cancer Journal for Clinicians, 1971M E Shils
exaly